NCT01518517 2022-02-02
GRASPIVOTALL
ERYtech Pharma
Phase 2/3 Completed
ERYtech Pharma
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
The University of Hong Kong
M.D. Anderson Cancer Center
University Hospital, Lille